High rate of Healthcare Associated Infections in a Nigerian Tertiary Hospital: A Point Prevalence Survey Highlighting Neonatal and Paediatric Vulnerability Authors: M Z Sabitu, Y Mohammed, O O Oduyebo, T Yusuf, I N Nwafia, I W Isa Musa, BG Aljannare, J Abubakar, Y Saminu, K M Dada, H Mathew, U Faruk, A Versporten Published: 2026 ABSTRACT Background:Healthcare-associated infections (HAIs) are a major patient safety threat globally, with high burdens in low- and middle-income countries (LMICs). In Nigeria, data on HAIs are limited, affecting effective infection prevention and control (IPC) strategies. This study evaluated the prevalence, types, and risk factors of HAIs at Usmanu Danfodiyo University Teaching Hospital (UDUTH) using the Global Point Prevalence Survey (GPPS) HAIs section.Methodology:A cross-sectional point prevalence survey was conducted from 21–25 October 2024 across all inpatient wards using standardised GPPS protocols. All patients admitted before 08:00 on survey days were included. Data were collected on the presence of HAIs, infection types, invasive device use, prior hospitalisations, surgery during admission, and severity of underlying conditions using the McCabe score. Comparisons between patients with and without HAI were made using chi square.Results:Among 262 inpatients, HAI prevalence was 14.5% (38/262), with significantly higher prevalence in paediatric/neonatal wards than adult wards (31.0% vs 11.4%; p = 0.001). Common HAIs included other infections (6.5%), bloodstream infections (5.3%), and surgical-site infections (2.7%). HAIs were associated with peripheral vascular catheter use, surgery, and fatal McCabe score. Peripheral vascular catheters were most frequently used (78.2%), followed by urinary (27.1%) and central venous catheters (1.5%).Conclusion:UDUTH revealed a high rate of HAIs, particularly affecting vulnerable children and neonatal populations, with bloodstream infections among the most reported types. These findings underscore an urgent need for improved IPC programmes, strengthened surveillance systems, targeted interventions in high risk wards, and enhanced diagnostic capacity to guide HAIs prevention strategies. Introduction Healthcare-associated infections (HAIs) are among the most common adverse events in healthcare, associated with substantial burdens on patient safety, outcomes, and healthcare costs.1 WHO estimates that hundreds of millions of patients are affected annually, with the highest burden in low- and middle-income countries (LMICs).1,2 In LMICs, about 1 in 5 hospitalised patients (22%) acquires HAIs; surgical site infections are most common (27%).3 This emphasises the urgent need for better infection prevention in resource-limited settings. A five-year audit from a tertiary hospital in Nigeria reported an overall HAI prevalence of 2.6% (95% CI 2.4–2.8), with urinary tract infections (43.9%) and surgical site infections (30.7%) predominating.4 HAIs are linked to antimicrobial resistance (AMR); however, AMR data from African countries are limited, a critical gap that hinders effective containment policies and intervention monitoring.5 The Global Point Prevalence Survey (GPPS) protocol, developed by the University of Antwerp, provides a standardised methodology for evaluating both antimicrobial consumption and HAIs prevalence.6 The optional HAIs module of GPPS allows hospitals to generate data on infection rates, types, device use and risk factors, which are essential for targeted IPC interventions and resource allocation.7 Usmanu Danfodiyo University Teaching Hospital (UDUTH), a major tertiary referral centre in north-western Nigeria, admits many patients at high risk for HAIs. This study therefore employed the GPPS HAIs module to establish a baseline of HAIs prevalence, types and risk factors at UDUTH to guide IPC strategy development and resource prioritisation. Methods Study Design, Setting, and Data Collection A cross-sectional point prevalence survey was conducted at UDUTH, a 1000-bed tertiary facility in Sokoto, north-western Nigeria, adhering to the standardised GPPS protocol including the optional HAIs module. Data were collected from 21–25 October 2024, with all inpatient wards surveyed on a single pre-assigned day. All eligible inpatients admitted before 08:00 on the survey day were included; no priority sample size calculation was performed, consistent with the GPPS study survey approach. Fifteen data collectors (doctors and nurses) underwent standardised virtual training by Management Sciences for Health (MSH) under the Fleming Fund project, ensuring competency in GPPS methodology, HAIs case definitions, data collection tools, and interview techniques. During data collection, completed forms were checked for completeness and consistency by a supervisor; after entry, the GPPS platform's built-in validation rules flagged missing or implausible values, which were resolved by re-checking source documents. Study investigators provided ongoing supervision to maintain data quality. Using standardised forms, collectors recorded demographics, admission date, HAIs presence, invasive device use (peripheral vascular catheter [PVC], central venous catheter [CVC], urinary catheter, tubes/drains, intubation), risk factors (prior hospitalisation within 3 months, surgery during admission, antibiotic exposure within 1 month), and McCabe score for underlying condition severity. HAIs definitions followed CDC/NHSN criteria; infections present at admission were excluded, and only those meeting all criteria elements on or after the third hospital day were classified as HAIs.8,9 Case sorting relied on clinical documentation and available laboratory results; all suspected HAIs cases were reviewed by a team that included medical microbiologists to confirm that CDC/NHSN criteria were met; however, microbiological confirmation was not available for a significant number of cases. The GPPS platform captures the origin of each HAI (this hospital, another hospital, long-term care facility [LTCF], or unknown). Data Analysis Data were directly entered and validated on the secure, web-based GPPS platform (www.global-pps.com). Analysis comprised descriptive statistics (frequencies and proportions) to summarise HAIs prevalence, infection types, device utilisation, and risk factor distributions. Differences in HAIs prevalence between ward types were assessed with the chi-square test. Additionally, univariate comparisons between patients with and without HAIs were performed for selected risk factors (device use, prior hospitalisation, surgery, antibiotic exposure, McCabe score) using the chi-square and Fisher's exact tests as appropriate. A p-value <0.05 was considered significant. All analyses were performed using SPSS version 26.0 (IBM Corp., Armonk, NY, USA). Ethical Considerations Ethical approval was granted by the UDUTH Health Research Ethics Committee (Approval No: UDUTH/HREC/2024/1471/v1, dated 10 December 2024). Patient data were anonymised as no patient identifiers were recorded on data collection forms. The survey was conducted as part of routine quality improvement activities, with no additional interventions beyond standard care. This manuscript was prepared following the STROBE checklist for cross-sectional studies and the GPPS reporting recommendations. Results Patient Characteristics and HAI Prevalence A total of 262 inpatients were surveyed across all wards. The overall HAI prevalence was 14.5% (38/262 patients). Type of wards analysis revealed statistically significant variation (p = 0.001), with paediatric and neonatal wards demonstrating the highest HAIs rate at 31.0% (13/42 patients), compared with 11.4% (25/220 patients) in adult wards (Table 1; Figure 1). Bar chart showing prevalence of healthcare-associated infections among inpatients, stratified by ward type Table 1Prevalence of healthcare associated infections among inpatients, stratified by type of wardsType of wardsPatients Surveyed (N)Patients with HAIs (N)HAIs Prevalence (%)p-value All Inpatients 2623814.5– Adult Wards 2202511.40.001*Medical (AMW)1141311.40.002Surgical (ASW)1001111.00.003Intensive Care (AICU)6116.7Descriptive only Children & 42 13 31.0 – Neonatal Wards Paediatric Medical (PMW)36822.20.01Paediatric Surgical (PSW)6116.70.06 Neonatal (NMW/NICU) 23 4 17.4 – Prevalence of healthcare associated infections among inpatients, stratified by type of wards The neonatal ward row is shown separately; the paediatric/neonatal total (n=42) was used for the chi-square test. ICU figures are descriptive owing to the very small sample size. Types and Sources of Healthcare-Associated Infections The most frequent HAIs types for the hospital were other HAIs (6.5% of all patients, 44.7% of HAIs), bloodstream infections (5.3%, 36.8% of HAIs), and postoperative surgical site infections (2.7%, 18.4% of HAIs). Intervention-related infections accounted for 0.8% (Table 2). No cases of Clostridioides difficile-associated diarrhoea (CDAD) were documented. The origin of HAIs is shown in Table 3: 16 infections (42.1%) originated from this hospital, while 3 (7.9%) were acquired in another hospital and 14 (36.8%) were classified as LTCF/nursing home origin. No central line-associated bloodstream infection (CLABSI), ventilator-associated pneumonia (VAP), or catheter-associated urinary tract infection (CAUTI) was documented. Table 2Types and sources of healthcare associated infectionsType of HAIsPatients (N=262)Percentage (%)Proportion of HAIs (%)Bloodstream infection (BSI)145.336.8Postoperative SSI72.718.4Intervention-related infection20.85.3Mixed infection origin20.85.3Other HAIs176.544.7CDAD00.00.0Note: SSI = surgical site infection; CDAD = Clostridioides difficile-associated diarrhoea. Device-associated infections (CLABSI, CAUTI, VAP) were not identified in this survey. Types and sources of healthcare associated infections Note: SSI = surgical site infection; CDAD = Clostridioides difficile-associated diarrhoea. Device-associated infections (CLABSI, CAUTI, VAP) were not identified in this survey. Table 3Origin of healthcare-associated infectionsOriginHAIs cases (N=38)Percentage of HAIs (%)This hospital1642.1Another hospital37.9LTCF / nursing home1436.8Unknown513.2Note: LTCF = long-term care facility. Origin of healthcare-associated infections Note: LTCF = long-term care facility. HAI Patterns by Ward Type Paediatric and neonatal wards showed a distinct HAI profile, with bloodstream infections present in 14.3% of patients and other HAIs in 16.7% (Table 4). Postoperative SSIs occurred in 4.8% of this population Table 4Types of HAIs in paediatric and neonatal wards (N=42)HAI TypePatients (n)Percentage (%)Bloodstream infection614.3Other HAIs716.7Postoperative SSI24.8 Types of HAIs in paediatric and neonatal wards (N=42) Adult wards showed a different pattern (Table 5). Other HAIs were present in 4.5%, bloodstream infections in 3.6%, and postoperative SSIs in 2.3%. Intervention-related infections were rare (0.9%) Table 5Types of HAI in adult wards (N=220)TypePatients (n)Percentage (%)Other HAIs104.5Bloodstream infection83.6Postoperative SSI52.3Intervention-related (mixed)20.9 Types of HAI in adult wards (N=220) Invasive Device Use Use of medical devices was common (Table 6). PVCs were used in 78.2% of patients, indwelling urinary catheters in 27.1%, and CVCs in 1.5%. Surgical tubes/drains were present in 3.4%, and invasive intubation in 0.8%. Table 6Invasive device use by ward typeDeviceHospital-wide (N=262)Adult Wards (N=220)Adult ICU (N=64)Adult Medical (N=114)Adult Surgical (N=100)Children/Neonatal (N=42)PVC (%)78.275.0100.075.473.095.2CVC (%)1.51.816.71.81.00.0Indwelling UC (%)27.131.883.325.436.02.4Tubes/Drains (%)3.43.633.30.95.02.4Invasive intubation (%)0.80.90.00.0PVC = peripheral vascular catheter; CVC = central venous catheter; UC = urinary catheter Invasive device use by ward type PVC = peripheral vascular catheter; CVC = central venous catheter; UC = urinary catheter Risk Factors for Healthcare-Associated Infections Prior hospitalisation within 3 months was reported in 10.8% of patients, surgery during admission in 31.3%, and antibiotic exposure within 1 month in 11.6%. McCabe score classification showed 64.1% had non-fatal diseases, 20.5% ultimately fatal conditions, and 1.5% rapidly fatal diseases; 13.8% had unknown status. Comparison of Patients with and Without HAIs Table 7 presents univariate comparisons. HAIs were significantly associated with PVC use (86.8% vs. 76.8%, p=0.03), surgery during admission (52.6% vs. 27.4%, p<0.001), and ultimately fatal McCabe score (36.8% vs. 17.9%, p=0.01). Prior hospitalisation and antibiotic exposure were more frequent in HAI patients but did not reach statistical significance. Table 7Characteristics of patients with and without healthcare-associated infectionCharacteristicHAI (n=38) presentHAI (n=224) absentp-valuePVC use, n (%)33 (86.8)172 (76.8)0.03CVC use, n (%)1 (2.6)3 (1.3)0.47Urinary catheter, n (%)12 (31.6)59 (26.3)0.56Surgery during admission, n (%)20 (52.6)55/201 (27.4)*<0.001Prior hospitalisation (<3 months), n (%)7/32 (21.9)*21/152 (13.8)*0.28Antibiotic exposure (<1 month), n (%)7/33 (21.2)*15/156 (9.6)*0.07Ultimately/rapidly fatal McCabe score, n (%)14 (36.8)43 (17.9) **0.01*Denominator varies because of missing data; patients with unknown status were excluded.**43/224 (19.2%) when combining rapidly and ultimately fatal; shown as 17.9% ultimately fatal alone for clarity. Characteristics of patients with and without healthcare-associated infection *Denominator varies because of missing data; patients with unknown status were excluded. **43/224 (19.2%) when combining rapidly and ultimately fatal; shown as 17.9% ultimately fatal alone for clarity. Discussion This point prevalence survey reveals a high HAI burden at UDUTH (14.5%), with a striking vulnerability of paediatric and neonatal populations (31.0%). These figures are consistent with pooled estimates from other Nigerian tertiary hospitals (14.3–15.75%)10,11 and fall within the wide range reported across sub-Saharan Africa.11 The disparity with high-income settings (e.g., 6.5% in Europe12) highlights persistent gaps in IPC infrastructure and surveillance in Nigerian facilities.13 Children and neonates showed a high rate of HAIs in our survey, a finding that shows similar patterns seen in other LMICs where preterm infants' immature immunity, high device utilisation, and overcrowding amplify infection risk.13,14 Bloodstream infections were among the most commonly recorded HAIs (5.3% of all patients, 14.3% in paediatric wards), although the single-day PPS design and inconsistent microbiological results likely underestimate their true frequency. The absence of documented device-associated infections (CLABSI, CAUTI, VAP) may reflect the limitations of a point prevalence survey and under utilisation of diagnostic capacity rather than true absence; therefore, we cannot attribute this solely to under-detection without further validation. High utilisation of peripheral catheters (78.2%) and urinary catheters (27.1%) creates numerous portals for infection. The univariate associations between HAIs and PVC use, surgery, and ultimately fatal McCabe score align with known risk factors in LMICs.15 However, because these comparisons are unadjusted and based on a small number of HAI cases, they should be interpreted as hypothesis-generating. The high “LTCF” origin (36.8% of HAIs) must be interpreted cautiously; the GPPS offers fixed categories, and in the Nigerian setting where formal long-term care facilities are rare, this field likely captures patients referred from other hospitals or chronic-care wards. Future surveys should incorporate local validation of these designations. The observed HAIs rate has direct implications for antimicrobial resistance. HAIs, particularly BSIs, often drive empiric broad-spectrum antibiotic use, which in turn selects for resistant organisms.16,17 At UDUTH, a concurrent prescribing survey reported 74.4% antimicrobial prevalence, 61% Watch-category antibiotic use, and low rates of targeted therapy (14.3%)18, underscoring the need for integrated HAIs surveillance and antimicrobial stewardship. Limitations This single-centre, cross-sectional survey provides a snapshot; seasonal variation and outbreak periods are not captured. HAIs diagnosis relied on clinical records and available laboratory data, so some infections, especially those requiring microbiological confirmation, may have been missed. Post-discharge SSIs were not captured. Small subgroup sizes (ICU, neonatal) limit statistical power. Multivariable analysis was not feasible because of the modest number of HAI events. Finally, we did not collect microbiological resistance data on HAI isolates. Despite these limitations, this study provides essential baseline HAIs data for UDUTH. Conclusion This point prevalence survey at UDUTH found a high HAI prevalence of 14.5%, and up to 31.0% in paediatric and neonatal wards. Bloodstream infections were among the most commonly reported HAIs, invasive device use was widespread, and significant risk factors were present. To reduce this burden, the IPC committee should be empowered with clear targets, implement evidence-based bundles for neonatal BSI and SSI prevention, strengthen surveillance through quarterly PPS and post-discharge monitoring, and improve microbiological diagnostic utilisation. A follow-up survey within 12 months is recommended to track progress.